T3011
MVR-T3011-ES-EC61-MA
Phase 1 small_molecule active
Quick answer
T3011 for Malignant Ascites is a Phase 1 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Malignant Ascites
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active